Headlines
- Isis Pharmaceuticals to Present a General Corporate Update at its 2013 Annual Meeting of Stockholders and Open HousePR Newswire(Tue Jun 18)
- Isis Pharmaceuticals Making Antisenseat Seeking Alpha(Mon Jun 17)
- Near A 52-Week Low, Is OncoGenex Pharmaceuticals A Buy?at Seeking Alpha(Thu Jun 13)
- Isis Pharmaceuticals' Management Presents at Goldman Sachs 34th Annual Global Healthcare Conference (Transcript)at Seeking Alpha(Wed Jun 12)
- Isis Stock Hits New 52-Week High (ISIS)at TheStreet(Tue Jun 11)
- Xenon Licenses Isis DrugZacks(Tue Jun 11)
- 4 Healthcare Stock Stories Deserving of Monday Attentionat Wall St. Cheat Sheet(Mon Jun 10)
- Google Nears Waze Deal, Honda and TRW Cope With Recall, and 2 More Hot Stocksat Wall St. Cheat Sheet(Mon Jun 10)
- Xenon licenses antisense drug SEN701 from Isis Pharmaceuticalstheflyonthewall.com(Mon Jun 10)
- Xenon Licenses Antisense Drug XEN701 From Isis and Initiates Preclinical Toxicology StudiesPR Newswire(Mon Jun 10)
- Miss ISIS's $19 Secondary But Think It's A Steal At $12?at Forbes(Fri Jun 7)
- 4 Healthcare Stock Stories Creating a Thursday Buzzat Wall St. Cheat Sheet(Thu Jun 6)
- Encouraging Data on Isis CandidateZacks(Thu Jun 6)
- Isis Pharmaceuticals Earns $6 Million Payment from AstraZenecaPR Newswire(Thu Jun 6)
- A New Approach to Treating CancerAccesswire(Wed Jun 5)
Press Releases
- A New Approach to Treating CancerAccesswire(Wed Jun 5)
- Wall Street Fundamentals Releases New In-Depth Stock Reports on ARRY, INFI, ISIS and NVAXAccesswire(Mon Jun 3)
- Investors Begin To Realize RNA’s PotentialAccesswire(Tue May 21)
Must Read
- Airbus pieces together air show order finaleReuters(Wed Jun 19)
- US stocks slide, Treasury yields spike after Bernanke says Fed could slow bond purchasesThe Canadian Press(Wed Jun 19)
- Hudson's Bay says it's not just a retailer, but a hangout for shoppersThe Canadian Press(Wed Jun 19)
- Bernanke says Fed likely to reduce bond buying this yearReuters(Wed Jun 19)
- Bank of Canada Stephen Poloz chummy in debut(Wed Jun 19)
